celh-20250331Q120250001341766--12-31False11290.0711460xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purecelh:segment00013417662025-01-012025-03-3100013417662025-04-3000013417662025-03-3100013417662024-12-310001341766us-gaap:SeriesAPreferredStockMember2024-12-310001341766us-gaap:SeriesAPreferredStockMember2025-03-310001341766us-gaap:RelatedPartyMember2025-03-310001341766us-gaap:RelatedPartyMember2024-12-3100013417662024-01-012024-03-310001341766us-gaap:RelatedPartyMember2025-01-012025-03-310001341766us-gaap:RelatedPartyMember2024-01-012024-03-310001341766us-gaap:CommonStockMember2024-12-310001341766us-gaap:AdditionalPaidInCapitalMember2024-12-310001341766us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001341766us-gaap:RetainedEarningsMember2024-12-310001341766us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001341766us-gaap:CommonStockMember2025-01-012025-03-310001341766us-gaap:RetainedEarningsMember2025-01-012025-03-310001341766us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001341766us-gaap:CommonStockMember2025-03-310001341766us-gaap:AdditionalPaidInCapitalMember2025-03-310001341766us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001341766us-gaap:RetainedEarningsMember2025-03-310001341766us-gaap:CommonStockMember2023-12-310001341766us-gaap:AdditionalPaidInCapitalMember2023-12-310001341766us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001341766us-gaap:RetainedEarningsMember2023-12-3100013417662023-12-310001341766us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001341766us-gaap:CommonStockMember2024-01-012024-03-310001341766us-gaap:RetainedEarningsMember2024-01-012024-03-310001341766us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001341766us-gaap:CommonStockMember2024-03-310001341766us-gaap:AdditionalPaidInCapitalMember2024-03-310001341766us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001341766us-gaap:RetainedEarningsMember2024-03-3100013417662024-03-310001341766celh:AlaniNuMember2025-02-202025-02-200001341766celh:AlaniNuMember2025-02-200001341766celh:TransitionAgreementMemberus-gaap:ConvertiblePreferredStockMember2022-08-012022-08-010001341766celh:AlaniNuMember2025-03-310001341766us-gaap:ProductConcentrationRiskMembercelh:PowderMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001341766us-gaap:ProductConcentrationRiskMembercelh:PowderMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001341766celh:PepsicoIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001341766celh:PepsicoIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001341766celh:AmazonMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001341766celh:AmazonMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001341766celh:CostcoMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001341766celh:CostcoMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001341766celh:AllOtherMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001341766celh:AllOtherMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001341766us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-01-012025-03-310001341766us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-03-310001341766celh:PepsicoIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-03-310001341766celh:PepsicoIncMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310001341766celh:AmazonMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-03-310001341766celh:AmazonMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-03-310001341766celh:CostcoMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-03-310001341766celh:CostcoMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310001341766celh:AllOtherMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-03-310001341766celh:AllOtherMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310001341766us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2025-01-012025-03-310001341766us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-12-310001341766srt:NorthAmericaMember2025-03-310001341766srt:NorthAmericaMember2024-12-310001341766country:FI2025-03-310001341766country:FI2024-12-310001341766country:SE2025-03-310001341766country:SE2024-12-310001341766country:IE2025-03-310001341766country:IE2024-12-310001341766celh:OtherMember2025-03-310001341766celh:OtherMember2024-12-310001341766celh:GeographicalLocationsForeignOperationsExcludingIrelandSwedenAndFinlandMember2025-03-310001341766celh:GeographicalLocationsForeignOperationsExcludingIrelandSwedenAndFinlandMember2024-12-310001341766srt:NorthAmericaMember2025-01-012025-03-310001341766srt:NorthAmericaMember2024-01-012024-03-310001341766srt:EuropeMember2025-01-012025-03-310001341766srt:EuropeMember2024-01-012024-03-310001341766srt:AsiaPacificMember2025-01-012025-03-310001341766srt:AsiaPacificMember2024-01-012024-03-310001341766celh:OtherMember2025-01-012025-03-310001341766celh:OtherMember2024-01-012024-03-310001341766celh:PepsicoIncMember2025-01-012025-03-310001341766celh:PepsicoIncMember2022-08-012022-08-010001341766celh:PepsicoIncMember2023-01-012023-12-310001341766celh:BigBeveragesContractManufacturingLLCMember2024-11-010001341766celh:BigBeveragesContractManufacturingLLCMember2024-11-012024-11-010001341766celh:BigBeveragesContractManufacturingLLCMember2025-03-310001341766celh:BigBeveragesContractManufacturingLLCMemberus-gaap:CustomerRelationshipsMember2024-11-012024-11-010001341766celh:BigBeveragesContractManufacturingLLCMemberus-gaap:CustomerRelationshipsMember2024-11-010001341766celh:BigBeveragesContractManufacturingLLCMemberus-gaap:TradeNamesMember2024-11-012024-11-010001341766celh:BigBeveragesContractManufacturingLLCMemberus-gaap:TradeNamesMember2024-11-010001341766srt:MinimumMembercelh:MerchandisingEquipmentCoolersMember2025-03-310001341766srt:MaximumMembercelh:MerchandisingEquipmentCoolersMember2025-03-310001341766celh:MerchandisingEquipmentCoolersMember2025-03-310001341766celh:MerchandisingEquipmentCoolersMember2024-12-310001341766us-gaap:VehiclesMember2025-03-310001341766us-gaap:VehiclesMember2024-12-310001341766srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2025-03-310001341766srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2025-03-310001341766us-gaap:MachineryAndEquipmentMember2025-03-310001341766us-gaap:MachineryAndEquipmentMember2024-12-310001341766srt:MinimumMemberus-gaap:LeaseholdImprovementsMember2025-03-310001341766srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2025-03-310001341766us-gaap:LeaseholdImprovementsMember2025-03-310001341766us-gaap:LeaseholdImprovementsMember2024-12-310001341766srt:MinimumMemberus-gaap:OfficeEquipmentMember2025-03-310001341766srt:MaximumMemberus-gaap:OfficeEquipmentMember2025-03-310001341766us-gaap:OfficeEquipmentMember2025-03-310001341766us-gaap:OfficeEquipmentMember2024-12-310001341766us-gaap:CustomerRelationshipsMembersrt:MinimumMember2025-03-310001341766us-gaap:CustomerRelationshipsMembersrt:MaximumMember2025-03-310001341766us-gaap:TradeNamesMember2025-03-310001341766celh:StrongArmProductionsLawsuitMember2025-03-310001341766celh:StrongArmProductionsLawsuitMember2024-12-310001341766us-gaap:SeriesAPreferredStockMember2022-08-010001341766us-gaap:RelatedPartyMember2022-08-010001341766us-gaap:RelatedPartyMember2025-01-012025-03-310001341766us-gaap:RelatedPartyMember2023-01-012023-12-310001341766us-gaap:RelatedPartyMember2024-01-012024-03-310001341766us-gaap:RelatedPartyMemberus-gaap:SeriesAPreferredStockMember2022-08-012022-08-010001341766us-gaap:RelatedPartyMember2022-08-012022-08-010001341766celh:SecuritiesPurchaseAgreementMemberus-gaap:SeriesAPreferredStockMember2022-08-012022-08-010001341766us-gaap:SeriesAPreferredStockMember2022-08-012022-08-0100013417662023-11-132023-11-130001341766us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310001341766celh:SecuritiesPurchaseAgreementMemberus-gaap:SeriesAPreferredStockMember2025-03-310001341766us-gaap:SeriesAPreferredStockMember2023-11-142023-11-140001341766us-gaap:SeriesAPreferredStockMember2023-11-152023-11-150001341766us-gaap:SeriesAPreferredStockMember2024-01-012024-03-310001341766celh:EightPercentageMember2025-01-012025-03-310001341766celh:TenPercentageMember2025-01-012025-03-310001341766celh:TwelvePercentageMember2025-01-012025-03-310001341766celh:The2015StockIncentivePlanMember2025-01-012025-03-310001341766celh:The2015StockIncentivePlanMember2025-03-310001341766celh:RestrictedStockUnitsAndPerformanceStockUnitsMember2024-12-310001341766celh:RestrictedStockUnitsAndPerformanceStockUnitsMember2023-12-310001341766celh:RestrictedStockUnitsAndPerformanceStockUnitsMember2025-01-012025-03-310001341766celh:RestrictedStockUnitsAndPerformanceStockUnitsMember2024-01-012024-03-310001341766celh:RestrictedStockUnitsAndPerformanceStockUnitsMember2025-03-310001341766celh:RestrictedStockUnitsAndPerformanceStockUnitsMember2024-03-310001341766us-gaap:PerformanceSharesMember2025-01-012025-03-310001341766us-gaap:PerformanceSharesMembercelh:ValuationRevenueApproachMember2025-03-310001341766us-gaap:PerformanceSharesMembercelh:ValuationTotalShareholderReturnVs.PeerGroupApproachMember2025-03-310001341766celh:ReportableSegmentMember2025-01-012025-03-310001341766celh:ReportableSegmentMember2024-01-012024-03-310001341766celh:DerivativeActionsRelatedTo2022RestatementMember2024-12-132024-12-130001341766celh:FAndLMembercelh:DthreemLicensingGroupMember2021-05-042021-05-0400013417662023-01-182023-01-1800013417662023-04-272023-04-270001341766srt:MinimumMember2025-02-060001341766srt:MaximumMember2025-02-060001341766celh:AlaniNuMemberus-gaap:SubsequentEventMember2025-04-012025-04-010001341766celh:AlaniNuMemberus-gaap:SubsequentEventMember2025-04-010001341766celh:TermLoanFacilityMemberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMember2025-04-010001341766celh:TermLoanFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMember2025-04-010001341766celh:JohnFieldlySeptember2024PlanMembercelh:JohnFieldlyMember2025-01-012025-03-310001341766celh:JohnFieldlySeptember2024PlanMembercelh:JohnFieldlyMember2025-03-310001341766celh:JohnFieldlyMarch2025PlanMembercelh:JohnFieldlyMember2025-01-012025-03-310001341766celh:JohnFieldlyMarch2025PlanMembercelh:JohnFieldlyMember2025-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2025
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-34611
CELSIUS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
| | | | | | | | |
Nevada | | 20-2745790 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | |
2381 NW Executive Center Drive, Boca Raton, Florida | | 33431 |
(Address of principal executive offices) | | (Zip Code) |
(561) 276-2239
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, $0.001 par value per share | | CELH | | Nasdaq Capital Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | |
Large accelerated filer | x | Accelerated filer | o |
Non-accelerated filer | o | Smaller reporting company | o |
| | Emerging growth company | o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of April 30, 2025, the registrant had 257,741,256 shares of common stock, $0.001 par value per share, outstanding.
TABLE OF CONTENTS
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
Celsius Holdings, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| | | | | | | | | | | |
| (Unaudited) | | |
| March 31, 2025 | | December 31, 2024 |
ASSETS | | | |
Current assets: | | | |
Cash and cash equivalents | $ | 977,285 | | | $ | 890,190 | |
Accounts and note receivable-net[1] | 256,424 | | | 270,342 | |
Inventories-net | 141,159 | | | 131,165 | |
Deferred other costs-current[2] | 14,124 | | | 14,124 | |
Prepaid expenses and other current assets | 22,464 | | | 18,759 | |
Total current assets | 1,411,456 | | | 1,324,580 | |
| | | |
Property, plant and equipment-net | 58,698 | | | 55,602 | |
Right of use assets-operating leases | 20,866 | | | 21,606 | |
| | | |
Intangibles-net | 12,444 | | | 12,213 | |
Goodwill | 72,128 | | | 71,582 | |
Deferred other costs-non-current[2] | 230,684 | | | 234,215 | |
Deferred tax assets | 38,525 | | | 38,699 | |
Other long-term assets | 14,717 | | | 8,384 | |
Total Assets | $ | 1,859,518 | | | $ | 1,766,881 | |
| | | |
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | | | |
Current liabilities: | | | |
Accounts payable[3] | $ | 61,052 | | | $ | 41,287 | |
Accrued expenses[4] | 152,046 | | | 148,780 | |
Income taxes payable | 26,206 | | | 10,834 | |
| | | |
Accrued promotional allowance[5] | 151,327 | | | 135,948 | |
Lease liability operating leases | 3,550 | | | 3,265 | |
| | | |
Deferred revenue[2] | 9,513 | | | 9,513 | |
Other current liabilities | 14,160 | | | 15,908 | |
Total current liabilities | 417,854 | | | 365,535 | |
| | | |
Lease liability operating leases | 16,152 | | | 16,674 | |
| | | |
| | | |
Deferred revenue[2] | 155,336 | | | 157,714 | |
Other long term liabilities | 2,574 | | | 2,541 | |
Total Liabilities | 591,916 | | | 542,464 | |
| | | |
Commitments and contingencies (Note 14) | | | |
| | | |
Mezzanine equity: | | | |
Series A convertible preferred stock, $0.001 par value, 5% cumulative dividends; 1,466,666 shares issued and outstanding at March 31, 2025 and December 31, 2024, aggregate liquidation preference of $550,000 as of March 31, 2025 and December 31, 2024. | 824,488 | | | 824,488 | |
Stockholders’ equity: | | | |
Common stock, $0.001 par value; 300,000,000 shares authorized, 235,283,266 and 235,013,960 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively. | 79 | | | 79 | |
Additional paid-in capital | 300,877 | | | 297,579 | |
Accumulated other comprehensive loss | (1,001) | | | (3,250) | |
Retained earnings | 143,159 | | | 105,521 | |
Total Stockholders’ Equity | 443,114 | | | 399,929 | |
Total Liabilities, Mezzanine Equity and Stockholders’ Equity | $ | 1,859,518 | | | $ | 1,766,881 | |
[1] Includes $136.8 million and $168.2 million from a related party as of March 31, 2025 and December 31, 2024, respectively.
[2] Amounts in this line item are associated with a related party for all periods presented.
[3] Includes $9.2 million and $1.7 million due to a related party as of March 31, 2025 and December 31, 2024, respectively.
[4] Includes $0.2 million and $0.2 million due to a related party as of March 31, 2025 and December 31, 2024, respectively.
[5] Includes $88.7 million and $75.1 million due to a related party as of March 31, 2025 and December 31, 2024, respectively.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
Celsius Holdings, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income
(in thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | |
| 2025 | | 2024 | | | | | |
Revenue[1] | $ | 329,276 | | | $ | 355,708 | | | | | | |
Cost of revenue | 156,903 | | | 173,501 | | | | | | |
Gross profit | 172,373 | | | 182,207 | | | | | | |
Selling, general and administrative expenses[2] | 120,342 | | | 99,017 | | | | | | |
Income from operations | 52,031 | | | 83,190 | | | | | | |
| | | | | | | | |
Other income (expense): | | | | | | | | |
| | | | | | | | |
Interest income, net | 7,846 | | | 9,612 | | | | | | |
| | | | | | | | |
Other, net | 1,116 | | | (341) | | | | | | |
Total other income | 8,962 | | | 9,271 | | | | | | |
| | | | | | | | |
Net income before provision for income taxes | 60,993 | | | 92,461 | | | | | | |
| | | | | | | | |
Provision for income taxes | (16,574) | | | (14,650) | | | | | | |
Net income | $ | 44,419 | | | $ | 77,811 | | | | | | |
| | | | | | | | |
Dividends on Series A convertible preferred stock[3] | (6,781) | | | (6,837) | | | | | | |
Income allocated to participating preferred stock[3] | (3,219) | | | (6,128) | | | | | | |
Net income attributable to common stockholders | $ | 34,419 | | | $ | 64,846 | | | | | | |
| | | | | | | | |
Other comprehensive income: | | | | | | | | |
Foreign currency translation gain (loss), net of income tax | 2,249 | | | (1,354) | | | | | | |
Comprehensive income | $ | 36,668 | | | $ | 63,492 | | | | | | |
| | | | | | | | |
Earnings per share: | | | | | | | | |
Basic | $ | 0.15 | | | $ | 0.28 | | | | | | |
Diluted | $ | 0.15 | | | $ | 0.27 | | | | | | |
Weighted average shares outstanding: | | | | | | | | |
Basic | 235,191 | | | 232,780 | | | | | | |
Diluted | 237,172 | | | 237,523 | | | | | | |
[1] Includes $189.7 million and $210.5 million for the three months ended March 31, 2025 and 2024, respectively, from a related party.
[2] Includes $0.8 million and $0.7 million for the three months ended March 31, 2025 and 2024, respectively, from a related party.
[3] Amounts in this line item are associated with a related party for all periods presented.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
Celsius Holdings, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity and Mezzanine Equity
(In thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Stockholders’ Equity | | Mezzanine Equity |
| Common Stock | | | | | | | | | | | | |
| Shares | | Amount | | Additional Paid-In Capital | | Accumulated Other Comprehensive Loss | | Retained Earnings | | Total Stockholders’ Equity | | Preferred Stock | | Amount |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Balance at December 31, 2024 | 235,014 | | $ | 79 | | | $ | 297,579 | | | $ | (3,250) | | | $ | 105,521 | | | $ | 399,929 | | | 1,467 | | | $ | 824,488 | |
Stock-based compensation | — | | — | | | 5,029 | | | — | | | — | | | 5,029 | | | — | | | — | |
Stock option exercises, RSUs and PSUs converted | 348 | | — | | | 338 | | | — | | | — | | | 338 | | | — | | | — | |
Dividends paid to Series A convertible preferred stock ($4.62 per share) | — | | — | | | — | | | — | | | (6,781) | | | (6,781) | | | — | | | — | |
Repurchase of common stock related to tax withholdings | (73) | | | — | | | (1,932) | | | — | | | — | | | (1,932) | | | — | | | — | |
Treasury Stock | (6) | | | — | | | (137) | | | — | | | — | | | (137) | | | — | | | — | |
Foreign currency translation | — | | — | | | — | | | 2,249 | | | — | | | 2,249 | | | — | | | — | |
Net income | — | | — | | | — | | | — | | | 44,419 | | | 44,419 | | | — | | | — | |
Balance at March 31, 2025 | 235,283 | | $ | 79 | | | $ | 300,877 | | | $ | (1,001) | | | $ | 143,159 | | | $ | 443,114 | | | 1,467 | | | $ | 824,488 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
Celsius Holdings, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity and Mezzanine Equity
(In thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Stockholders' Equity | | Mezzanine Equity |
| Common Stock | | | | | | | | | | | | |
| Shares | | Amount | | Additional Paid-In Capital | | Accumulated Other Comprehensive Loss | | (Accumulated Deficit) Retained Earnings | | Total Stockholders' Equity | | Preferred Stock | | Amount |
Balance at December 31, 2023 | 231,787 | | $ | 77 | | | $ | 276,717 | | | $ | (701) | | | $ | (12,053) | | | $ | 264,040 | | | 1,467 | | | $ | 824,488 | |
| | | | | | | | | | | | | | | |
Stock-based compensation | — | | — | | | 3,563 | | | — | | | — | | | 3,563 | | | — | | | — | |
Stock option exercises, RSUs and PSUs converted to common stock | 1,283 | | 1 | | | 967 | | | — | | | — | | | 968 | | | — | | | — | |
Dividends paid on Series A convertible preferred stock ($4.66 per share) | — | | — | | | — | | | — | | | (6,837) | | | (6,837) | | | — | | | — | |
Foreign currency translation | — | | — | | | — | | | (1,354) | | | — | | | (1,354) | | | — | | | — | |
Net income | — | | — | | | — | | | — | | | 77,811 | | | 77,811 | | | — | | | — | |
Balance at March 31, 2024 | 233,070 | | $ | 78 | | | $ | 281,247 | | | $ | (2,055) | | | $ | 58,921 | | | $ | 338,191 | | | 1,467 | | | $ | 824,488 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
Celsius Holdings, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
| | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2025 | | 2024 | | |
Cash flows from operating activities: | | | | | |
Net income | $ | 44,419 | | | $ | 77,811 | | | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | |
Depreciation and amortization | 2,611 | | | 1,229 | | | |
Allowance for credit losses[1] | 2,077 | | | 2,250 | | | |
Amortization of deferred other costs[2] | 3,531 | | | 3,531 | | | |
Inventory excess and obsolescence | 5,337 | | | 2,386 | | | |
| | | | | |
Stock-based compensation expense | 5,029 | | | 3,563 | | | |
Deferred income taxes-net | 269 | | | 6,450 | | | |
| | | | | |
Other operating activities | (1,014) | | | 361 | | | |
Changes in operating assets and liabilities: | | | | | |
Accounts and note receivable-net[3] | 11,841 | | | (18,664) | | | |
Inventories | 4,794 | | | 29,386 | | | |
Prepaid expenses and other current assets | (3,687) | | | (2,076) | | | |
Other long-term assets | (1,700) | | | (7,672) | | | |
Accounts payable[4] | 11,679 | | | (3,013) | | | |
Accrued expenses[5] | (8,673) | | | 1,750 | | | |
Income taxes payable | 15,353 | | | 8,250 | | | |
Accrued promotional allowance[6] | 15,379 | | | 29,414 | | | |
| | | | | |
Other current liabilities | (1,648) | | | 2,094 | | | |
| | | | | |
Deferred revenue[2] | (2,378) | | | (2,378) | | | |
Other long-term liabilities | 148 | | | (23) | | | |
Net cash provided by operating activities | 103,367 | | | 134,649 | | | |
| | | | | |
Cash flows from investing activities: | | | | | |
| | | | | |
Purchase of property, plant and equipment[7] | (6,944) | | | (4,525) | | | |
| | | | | |
| | | | | |
Net cash used in investing activities | (6,944) | | | (4,525) | | | |
| | | | | |
Cash flows from financing activities: | | | | | |
| | | | | |
| | | | | |
Cash dividends paid on Series A convertible preferred stock[2] | (6,781) | | | (6,837) | | | |
Repurchase of common stock related to tax withholdings | (1,932) | | | — | | | |
Payment of debt issuance costs | (2,195) | | | — | | | |
Other financing activities | 321 | | | 952 | | | |
Net cash used in financing activities | (10,587) | | | (5,885) | | | |
| | | | | |
Effect on exchange rate changes on cash and cash equivalents | 1,259 | | | (722) | | | |
Net increase in cash and cash equivalents | 87,095 | | | 123,517 | | | |
Cash and cash equivalents at beginning of the period | 890,190 | | | 755,981 | | | |
| | | | | |
Cash and cash equivalents at end of the period | $ | 977,285 | | | $ | 879,498 | | | |
Supplemental disclosures: | | | | | |
Cash paid for: | | | | | |
Taxes | $ | 669 | | | $ | 320 | | | |
[1] Includes $(0.3) million and $(0.1) million associated with a related party for the three months ended March 31, 2025 and 2024, respectively.
[2] Amounts in this line item are associated with a related party for all periods presented.
[3] Includes $31.4 million and $(10.9) million associated with a related party for the three months ended March 31, 2025 and 2024, respectively.
[4] Includes $7.5 million and $5.3 million associated with a related party for the three months ended March 31, 2025 and 2024, respectively.
[5] Includes $0.1 million and $0.3 million associated with a related party for the three months ended March 31, 2025 and 2024, respectively.
[6] Includes $13.6 million and $24.0 million associated with a related party for the three months ended March 31, 2025 and 2024, respectively.
[7] Includes $(3.7) million and $(2.5) million associated with a related party for the three months ended March 31, 2025 and 2024, respectively.
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
1. ORGANIZATION AND DESCRIPTION OF BUSINESS
Business Overview
Celsius Holdings, Inc. (the “Company” or “Celsius”) was incorporated under the laws of the State of Nevada on April 26, 2005.
Celsius is a functional energy drink company operating in the United States (“U.S.”) and internationally. The Company engages in the development, processing, marketing, sale, manufacturing, and distribution of functional energy drinks and other products to a broad range of consumers, including fitness enthusiasts. Celsius provides differentiated products with innovative formulas, many of which are clinically proven and meant to positively impact the lives of its consumers.
Celsius is marketed as a premium lifestyle and energy drink formulated to power active lifestyles. Celsius products are currently offered in major retail segments across the U.S., including conventional grocery, natural food stores, convenience stores, fitness centers, mass market retailers, vitamin specialty stores and e-commerce platforms. Additionally, the Company's products are available in select markets across Canada, Europe, and the Asia-Pacific region.
Acquisition of Alani Nu
On February 20, 2025, the Company announced that it had entered into a membership interest purchase agreement to acquire Alani Nutrition LLC, a Kentucky limited liability company ("Alani Nu"), from its equity holders, Max Clemons, Trey Steiger, Katy E. Schneider, R. Haydn Schneider and certain related trusts (collectively, the “Sellers”) for a total consideration comprising (i) $1,275.0 million in cash, subject to adjustment as set forth in the purchase agreement, (ii) an aggregate of 22,451,224 shares of the Company's common stock and (iii) up to $25.0 million in additional cash consideration, payable only if net sales of Alani Nu’s products meet or exceed an agreed upon target for 2025. On April 1, 2025, the Company completed the acquisition of Alani Nu. For additional information see Note 15. Subsequent Events.
Agreements with PepsiCo Inc.
On August 1, 2022, the Company entered into multiple agreements with PepsiCo Inc. (“Pepsi”), including a long-term agreement that resulted in Pepsi becoming the primary distribution supplier for Celsius products in the U.S. (the “Distribution Agreement”). Under this agreement, the Company granted Pepsi a right of first offer in the event the Company intends to manufacture, distribute or sell products in certain additional countries or channels during the term of the agreement.
In connection with entering into these agreements, the Company issued and sold to Pepsi approximately 1.5 million shares of the Company's Series A Convertible Preferred Stock (“Series A” or “Series A Preferred Stock”) in exchange for cash proceeds of $550 million, excluding transaction costs. For additional information regarding the Company's agreements with Pepsi, see Note 4. Revenue, Note 10. Related Party Transactions and Note 11. Mezzanine Equity.
2. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation — The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the condensed consolidated financial statements do not include all of the information and notes required by U.S. GAAP for annual audited condensed consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The results for the three months ended March 31, 2025 are not necessarily indicative of the results expected for any future period or the full year. These unaudited condensed consolidated financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company's Annual Report on Form 10-K (the “2024 Annual Report”) for the fiscal year ended December 31, 2024, as filed by the Company with the Securities and Exchange Commission (the "SEC"). These condensed consolidated financial statements and the accompanying notes should be read in conjunction with the 2024 Annual Report.
Principles of Consolidation — These condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in accordance with U.S. GAAP.
Business Combinations — The Company accounts for business combinations in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations ("ASC 805"). Under this guidance, the results of operations of an acquired business are included in the Company’s condensed consolidated financial statements and related notes prospectively from the acquisition date.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
The Company allocates the purchase consideration to the identifiable tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. Any excess of the purchase consideration over the fair value of net assets acquired is recognized as goodwill. During the measurement period, which does not exceed twelve months from the acquisition date, adjustments to the preliminary fair value estimates may be recorded as additional information becomes available. Measurement period adjustments, if applicable, are recognized in the reporting period in which the adjustments are determined and reflected as a prospective adjustment to goodwill.
Transaction costs associated with acquisitions, such as advisory, legal, and consulting fees, are expensed as incurred and included in selling, general and administrative expenses. For the three months ended March 31, 2025, the Company incurred transaction costs totaling approximately $9.1 million, all of which related to the Alani transaction.
Goodwill and indefinite-lived intangible assets recognized as part of acquisitions are subsequently tested for impairment in accordance with the Company’s accounting policy for goodwill and indefinite-lived intangible assets. See Note 8. Goodwill and Intangibles for further discussion of impairment testing.
Segment Reporting — Operating segments are defined as components of an enterprise that engage in business activities, maintain discrete financial information, and undergo regular review by the chief operating decision maker (the "CODM"), who is the Chief Executive Officer, to assess performance and allocate resources.
Although the Company operates in multiple geographical regions, it functions as a single operating segment because its operations and strategies are centrally designed and executed and remain significantly similar across these regions. The CODM evaluates operating results and allocates resources on a consolidated basis due to the significant economic interdependencies between the Company's geographical operations. As a result, the Company is managed as a single operating segment and has a single reportable segment. While the Company has a single reportable segment, applicable accounting guidance requires the disclosure of certain financial information for reportable segments. The Company adopted the provisions of ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures as of December 31, 2024. See Note 13. Segment Reporting.
Significant Estimates — The preparation of condensed consolidated financial statements and accompanying disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses, as well as disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. These estimates and judgements are reviewed on an ongoing basis and are revised when necessary. Significant estimates include promotional allowances, intangibles, assets and liabilities assumed as a part of business combinations, the allowance for current expected credit losses, leases, allowance for inventory obsolescence and sales returns, the useful lives of property, plant and equipment, impairment of goodwill and intangibles, deferred taxes and related valuation allowance, and the valuation of stock-based compensation.
Concentrations of Risk — The majority of the Company’s revenue is derived from the sale of CELSIUS® functional energy drinks. Powder sales accounted for approximately 4.6% and 4.1% of revenue for the three months ended March 31, 2025 and 2024, respectively.
Revenue from customers accounting for more than 10.0% of total revenue for the three months ended March 31, 2025 and 2024 was as follows:
| | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | |
| 2025 | | 2024 | | | | | | |
Pepsi | 57.6 | % | | 59.2 | % | | | | | | |
Amazon | 12.1 | % | | 8.0 | % | | | | | | |
Costco | 5.9 | % | | 10.2 | % | | | | | | |
All others | 24.4 | % | | 22.6 | % | | | | | | |
Total | 100.0 | % | | 100.0 | % | | | | | | |
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
Accounts receivable from customers accounting for more than 10.0% of total accounts receivable as of March 31, 2025 and December 31, 2024 were as follows:
| | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
Pepsi | 53.5 | % | | 62.2 | % |
Amazon | 14.4 | % | | 8.9 | % |
Costco | 11.2 | % | | 10.2 | % |
All others | 20.9 | % | | 18.7 | % |
Total | 100.0 | % | | 100.0 | % |
Cash Equivalents — The Company considers all highly liquid instruments with original maturities of three months or less, when purchased, to be cash equivalents. As of March 31, 2025 and December 31, 2024, the Company did not hold any instruments with original maturities exceeding three months.
Accounts Receivable and Current Expected Credit Losses — The Company is exposed to potential credit risks associated with its product sales and related accounts receivable, as it generally does not require collateral from its customers. The Company’s expected loss allowance for accounts receivable is determined using historical collection experience, current and expected future economic and market conditions, an assessment of the current status of customers’ trade accounts receivable, and where available, an evaluation of the financial condition and credit ratings of larger customers, including credit reports. Customers are pooled based on common risk factors, and the Company reassesses these customer pools on a periodic basis. The allowance for credit losses is based on aging of the accounts receivable balances and estimated credit loss percentages.
Changes in the allowance for expected credit losses for the three months ended March 31, 2025 were as follows:
| | | | | |
| Allowance for Expected Credit Losses |
Balance as of December 31, 2024 | $ | 5,278 | |
Current period change | 2,077 | |
| |
Balance as of March 31, 2025 | $ | 7,355 | |
Long-Lived Assets by Geographic Area — The following table consists of geographic long-lived asset information, which includes property, plant and equipment-net, right-of-use assets, and definite-lived intangibles-net and excludes goodwill and indefinite-lived intangibles, for individual countries that represent a significant portion of the total. All of the Company’s North American long-lived assets are located in the United States and Canada. Long-lived assets from Puerto Rico are included in the 'Other' category:
| | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
North America | $ | 73,023 | | | $ | 72,115 | |
| | | |
Finland | 11,261 | | | 10,950 | |
Sweden | 3,744 | | | 2,523 | |
Ireland | 3,673 | | | 3,599 | |
Other | 30 | | | 29 | |
Long-lived assets related to foreign operations | 18,708 | | | 17,101 | |
Long-lived assets-net | $ | 91,731 | | | $ | 89,216 | |
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
Advertising Costs — Advertising costs are expensed as incurred and charged to selling, general and administrative expenses. The Company mainly uses targeted marketing initiatives, such as sporting events, print, radio, and television advertising, alongside direct sponsorships and endorsements. The Company incurred advertising expenses of approximately $49.3 million and $46.5 million for the three months ended March 31, 2025 and 2024, respectively.
Income Taxes — Starting in 2025, the Company has come within the scope of the Organization for Economic Co-operation and Development's ("OECD") Pillar Two framework, which establishes a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds. Certain jurisdictions in which the Company operates have enacted their respective tax laws to comply with Pillar Two. As of now, the Company does not expect Pillar Two to have a material impact on its consolidated results of operation, financial position, or cash flows. The Company will continue to monitor pending legislation and implementation by individual countries.
Recently Issued Accounting Pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, introducing changes to income tax disclosures, primarily relating to effective tax rates and cash paid for taxes. This ASU requires companies to provide an annual rate reconciliation in both dollar figures and percentages, and changes the way annual income taxes paid are disclosed by all entities, necessitating a breakdown by federal, state, and foreign jurisdictions. The standard becomes effective for public business entities for fiscal years beginning after December 15, 2024. The Company plans to apply the new guidance on a prospective basis. The Company expects ASU 2023-09 to impact only disclosures with no effect on the Company's financial condition, results of operations or cash flows. The Company is currently assessing the impact of ASU 2023-09 on the Company's consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40), which was further clarified by ASU 2025-01 in January 2025. These standards enhance expense disclosures by requiring more detailed information on the types of expenses included in certain captions within the consolidated financial statements, including employee compensation, depreciation, amortization, and costs incurred related to inventory and manufacturing activities in income statement expense captions such as cost of sales and selling, general and administrative expenses. The guidance is effective for fiscal years beginning after December 15, 2026, including interim periods beginning after December 15, 2027, with early adoption permitted. The Company does not expect the adoption of ASU 2024-03 and ASU 2025-01 to impact the Company's financial condition, results of operations or cash flows and is currently assessing the impact of adoption on the Company's consolidated financial statements.
3. EARNINGS PER SHARE
The Company’s Series A Preferred Stock is classified as a participating security in accordance with ASC Topic 260, Earnings per Share (“EPS”). Net income allocated to the holders of Series A Preferred Stock is based on the Series A stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. The Series A Preferred Stock is not contractually obligated to share in losses.
Under the two-class method, for diluted EPS, net income is reallocated to the Series A Preferred Stock, and all potentially dilutive securities based on the contractual participating rights of the respective securities to share in the current earnings as if all of the earnings for the period had been distributed. Shares of common stock issuable under performance stock units ("PSUs") were excluded from the dilutive EPS calculation as the related target goals had not been met as of the reporting period end date.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
| | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | |
| 2025 | | 2024 | | | | | | |
Numerator: | | | | | | | | | |
Net income | $ | 44,419 | | | $ | 77,811 | | | | | | | |
Dividends on Series A convertible preferred stock | (6,781) | | | (6,837) | | | | | | | |
Income allocated to participating preferred stock | (3,219) | | | (6,128) | | | | | | | |
Net income attributable to common stockholders | $ | 34,419 | | | $ | 64,846 | | | | | | | |
| | | | | | | | | |
Effect of dilutive securities: | | | | | | | | | |
Allocation of earnings to participating securities | $ | 3,219 | | | $ | 6,128 | | | | | | | |
Reallocation of earnings to participating securities | (3,195) | | | (6,016) | | | | | | | |
Net income available to common stockholders after assumed conversions | $ | 34,443 | | | $ | 64,958 | | | | | | | |
| | | | | | | | | |
Denominator: | | | | | | | | | |
Weighted average shares of common stock outstanding, basic | 235,191 | | | 232,780 | | | | | | | |
Dilutive shares of common stock | 1,981 | | | 4,743 | | | | | | | |
Weighted-average shares of common stock outstanding, diluted | 237,172 | | | 237,523 | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Earnings per share: | | | | | | | | | |
Basic | $ | 0.15 | | | $ | 0.28 | | | | | | | |
Diluted | $ | 0.15 | | | $ | 0.27 | | | | | | | |
For each of the three months ended March 31, 2025 and 2024, approximately 22.0 million potentially dilutive securities were excluded from the computation of diluted earnings per share related to common stockholders, as their effect was antidilutive.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
4. REVENUE
The Company recognizes revenue when performance obligations under the terms of a contract with the customer are satisfied. The primary performance obligation is the promise to sell finished products to customers, including distributors, wholesalers, and retailers. Performance obligations are typically satisfied once control or title is transferred based on the commercial terms of the applicable agreements with customers, and traditionally such agreements do not allow for a right of return. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Revenue is recorded net of variable consideration, such as provisions for returns, discounts and allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling, general and administrative expenses, in the Company's condensed consolidated statements of operations and comprehensive income. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in incentives the Company offers to its customers and their customers.
Information about the Company’s revenues by geographical location for the three months ended March 31, 2025 and 2024 is as follows:
| | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | |
| 2025 | | 2024 | | | | | | |
North America | $ | 306,534 | | | $ | 339,512 | | | | | | | |
Europe | 18,659 | | | 14,142 | | | | | | | |
Asia-Pacific | 2,244 | | | 675 | | | | | | | |
Other | 1,839 | | | 1,379 | | | | | | | |
Revenue | $ | 329,276 | | | $ | 355,708 | | | | | | | |
All of the Company’s North American revenue was derived from the United States and Canada. Revenue from Puerto Rico is included in the 'Other' category.
Promotional (Billback) Allowances
The Company’s promotional allowance programs with its distributors or retailers are executed through separate agreements in the ordinary course of business (variable consideration). These agreements provide for one or more of the arrangements described below and are of varying duration. The Company’s billbacks are calculated based on various programs with distributors and retail customers, and accruals are established for the Company’s anticipated liabilities. These accruals are based on agreed upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and distributor and retail customer performance levels. Differences between estimated and actual promotional and other allowances are recognized in the period such differences are determined.
Promotional allowances are recorded as reductions to revenue and primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following:
•discounts from list prices to support price promotions to end-consumers by retailers;
•reimbursements given to distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products;
•the Company’s agreed share of fees given to distributors and/or directly to retailers for certain advertising, in-store marketing and promotional activities;
•the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers, club stores and/or wholesalers;
•incentives provided to distributors and/or retailers for achieving or exceeding certain predetermined volume goals or other incentive targets;
•discounted products; and
•contractual fees given to distributors for items sold below defined pricing targets.
For the three months ended March 31, 2025 and March 31, 2024, promotional allowances included as a reduction of revenue were $110.2 million and $95.0 million, respectively.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
Accrued promotional allowances were $151.3 million and $135.9 million as of March 31, 2025 and December 31, 2024, respectively.
Agreements with Pepsi
The Company executed multiple agreements with Pepsi on August 1, 2022, including the Distribution Agreement relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the U.S., excluding certain existing customer accounts and sales channels, and the U.S. Virgin Islands (collectively, the “Territory”). Under the Distribution Agreement, the Company granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in the Territory. The Distribution Agreement represents a master service agreement and can be canceled by either party without cause in the nineteenth year of the term (i.e., 2041), the twenty-ninth year of the term (i.e., 2051) and in each 10th year thereafter (i.e., 2061, 2071, etc.) by providing 12 months’ written notice to the other party on August 1st of the year preceding the year of termination. Except for a termination by the Company “with cause” or a termination by Pepsi “without cause,” (each as defined in the Distribution Agreement), the Company is required to pay Pepsi certain compensation upon a termination as specified in the Distribution Agreement.
The Company agreed to provide Pepsi a right of first offer in the event the Company intends to (i) manufacture, distribute or sell products in certain additional countries as specified in the Distribution Agreement or (ii) distribute or sell products in any future channels and distribution methods during the term of the Distribution Agreement. Pepsi agreed to meet and confer in good faith with the Company regarding the terms and conditions upon which Pepsi may be willing to sell or distribute the Company's products, either directly or through local sub-distributors in certain other additional countries. The Distribution Agreement includes other customary provisions, including non-competition covenants in favor of the Company, representations and warranties, indemnification provisions, insurance provisions, and confidentiality provisions. In the fourth quarter of 2023, under the terms of the Distribution Agreement, the Company and Pepsi agreed to extend distribution to the Canadian market, which commenced in January of 2024.
On August 1, 2022, the Company and Pepsi also executed a transition agreement providing for the Company’s transition of certain existing distribution rights in the Territory to Pepsi (the “Transition Agreement”). Under the terms of the Transition Agreement, Pepsi agreed to pay the Company up to $250.0 million in multiple tranches to facilitate the Company’s transition of certain distribution rights to Pepsi. The Company received $227.8 million from Pepsi that were contractually restricted to be used only to pay termination fees due to other distributors; any excess cash received over amounts due to other distributors was required to be refunded to Pepsi. During 2023, $34.8 million of such funds were refunded to Pepsi. As of and after December 31, 2023, there was no refund liability owed to Pepsi.
On March 23, 2024, the Company entered into Amendment No. 1 to the Distribution Agreement with Pepsi, pursuant to which the Company has agreed to provide Pepsi with an incentive program designed to incentivize and compensate Pepsi for its continued focus on and actions to support the Company. These incentives are accounted for as promotional allowances and recorded as a reduction to revenue.
5. ACQUISITION
On November 1, 2024, the Company acquired 100% of the outstanding voting equity interests of Big Beverages Contract Manufacturing, L.L.C. ("Big Beverages"), a longtime co-packer for Celsius located in Huntersville, North Carolina. The acquisition provides the Company with in-house manufacturing capacity including access to manufacturing and warehouse facilities and a skilled workforce. The total purchase consideration was cash of $75.3 million, which is net of $1.5 million of acquired cash. The transaction was accounted for as a business combination under ASC 805. There have been no changes to the purchase price allocation since December 31, 2024.
A summary of the allocation of the total purchase consideration is presented below:
| | | | | | | | | | | | | | | | | | | | | | | |
| Purchase Consideration | | Goodwill | | Property, Plant and Equipment Acquired | | Other Net Identifiable Assets Acquired |
Big Beverages Acquisition | $ | 76,812 | | | $ | 58,257 | | | $ | 13,254 | | | $ | 5,301 | |
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
The acquired intangible asset fair values consisted of the following, which are amortized on a straight-line basis over their estimated useful lives:
| | | | | | | | | | | |
| Estimated Useful Life in Years | | At November 1, 2024 |
Customer relationships | 6 | | $ | 900 | |
Trade name | 3 | | 500 | |
Intangibles | | | $ | 1,400 | |
The fair value of identifiable intangible assets was estimated using discounted cash flow models with Level 3 inputs. Customer relationships were valued using the multi-period excess earnings method, and the trade name was valued using the relief-from-royalty method. Goodwill recognized in the transaction reflects expected synergies, including enhanced manufacturing capabilities and the assembled workforce, and was allocated to the Company’s single reporting unit. Acquisition-related costs of approximately $0.3 million were expensed as incurred and recorded in selling, general and administrative expenses.
6. INVENTORIES
Inventories are valued at the lower of cost or net realizable value with costs approximating those determined under the first-in, first-out method. Changes in the inventory reserve are included in cost of revenue.
Inventories-net consist of the following:
| | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
Finished goods | $ | 117,354 | | | $ | 108,786 | |
Raw materials | 28,559 | | | 27,088 | |
Less: inventory reserve | (4,754) | | | (4,709) | |
Inventories-net | $ | 141,159 | | | $ | 131,165 | |
7. PROPERTY, PLANT AND EQUIPMENT
The following table summarizes the Company's property, plant and equipment balances and includes the estimated useful lives that are generally used to depreciate the assets on a straight-line basis:
| | | | | | | | | | | | | | | | | | |
| Estimated Useful Life in Years | | March 31, 2025 | | December 31, 2024 | |
Merchandising equipment - coolers | 3-7 | | $ | 43,441 | | | $ | 39,231 | | |
Vehicles | 5 | | 12,237 | | | 12,237 | | |
Machinery and equipment | 7-15 | | 11,683 | | | 10,136 | | |
Leasehold improvements | 3-5 | | 2,375 | | | 2,561 | | |
Office equipment | 3-7 | | 1,681 | | | 2,228 | | |
Less: accumulated depreciation | | | (12,719) | | | (10,791) | | |
Property, plant and equipment-net | | | $ | 58,698 | | | $ | 55,602 | | |
Depreciation expense amounted to approximately $2.4 million and $1.1 million for the three months ended March 31, 2025 and 2024, respectively, and is reflected in selling, general and administrative expenses.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
8. GOODWILL AND INTANGIBLES
As of March 31, 2025 and December 31, 2024, goodwill, net of the impact of foreign exchange rate fluctuations, was approximately $72.1 million and $71.6 million, respectively.
The carrying amount and accumulated amortization of definite-lived intangible assets, and the carrying amount of indefinite-lived intangible assets, net of the impact of foreign exchange rate fluctuations, as of March 31, 2025 and December 31, 2024, were as follows:
| | | | | | | | | | | | | | | | | |
| Estimated Useful Life in Years | | March 31, 2025 | | December 31, 2024 |
Definite-lived intangible assets | | | | | |
Customer relationships | 6-25 | | $ | 14,505 | | | $ | 13,970 | |
Trade name | 3 | | 500 | | | 500 | |
Less: accumulated amortization | | | (3,014) | | | (2,692) | |
Definite-lived intangible assets, net | | | $ | 11,991 | | | $ | 11,778 | |
| | | | | |
Indefinite-lived intangible assets | | | | | |
Brands | | | 453 | | | 435 | |
Intangibles-net | | | $ | 12,444 | | | $ | 12,213 | |
As of March 31, 2025 and December 31, 2024, there were no indicators of goodwill or intangible asset impairment. Amortization expense for the three months ended March 31, 2025 and 2024 was approximately $0.2 million and $0.1 million, respectively. Amortization expense is included in selling, general and administrative expenses.
The following table reflects the future estimated annualized amortization expense related to definite-lived intangible assets:
| | | | | |
2025 | $ | 642 | |
2026 | 856 | |
2027 | 829 | |
2028 | 690 | |
2029 | 690 | |
Thereafter | 8,284 | |
Total | $ | 11,991 | |
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
9. ACCOUNTS PAYABLE AND ACCRUED EXPENSES
As of March 31, 2025 and December 31, 2024, accounts payable was approximately $61.1 million and $41.3 million, respectively.
Accrued expenses consisted of the following:
| | | | | | | | | | | |
| March 31, 2025 | | December 31, 2024 |
Accrued legal | $ | 67,669 | | | $ | 63,328 | |
Accrued marketing | 30,240 | | | 34,774 | |
Unbilled purchases | 23,370 | | | 13,754 | |
Accrued freight | 7,077 | | | 5,098 | |
Contractual co-packer obligations | 1,980 | | | 9,350 | |
Other accrued expenses | 21,710 | | | 22,476 | |
Accrued expenses | $ | 152,046 | | | $ | 148,780 | |
As of March 31, 2025 and December 31, 2024, accrued legal included $55.9 million and $54.9 million, respectively, related to ongoing litigation, refer to Note 14. Commitments and Contingencies.
10. RELATED PARTY TRANSACTIONS
Transactions with Pepsi
As further described in Note 11. Mezzanine Equity, on August 1, 2022, the Company issued approximately 1.5 million shares of non-voting Series A Preferred Stock to Pepsi. The shares accounted for approximately 8.5% of the Company’s outstanding common stock on the date of issuance, on an if-converted method. The securities purchase agreement (the "Purchase Agreement"), pursuant to which Pepsi acquired the Series A Preferred Stock, grants Pepsi the right to designate a nominee for election to the Company’s Board of Directors (the "Board"), provided that Pepsi meets certain ownership requirements.
Pepsi provided the Company $227.8 million in cash under the Transition Agreement in 2022. This amount was used to settle termination fees with former distributors, and any excess cash was contractually restricted and due back to Pepsi. During the year ended December 31, 2023, $38.3 million of such funds were refunded to Pepsi. Amounts received pursuant to the Transition Agreement relating to the costs associated with terminating the Company’s prior distributors were accounted for as deferred revenue and are being recognized ratably over the 20 year term of the Distribution Agreement. Unamortized deferred revenues (current and non-current) are included as separate line items on the condensed consolidated balance sheets.
The Series A Preferred Stock was issued with a fair value of $832.5 million for an issuance price of $550.0 million. See Note 11. Mezzanine Equity. The Company recorded the $282.5 million excess as deferred costs on the condensed consolidated balance sheets. Costs are being amortized over the 20 year term of the Distribution Agreement and are recorded as an offset to revenue. Unamortized deferred other costs (current and non-current) are included as separate line items on the condensed consolidated balance sheets.
11. MEZZANINE EQUITY
Series A Convertible Preferred Stock
As of March 31, 2025 and December 31, 2024, the Company had designated and authorized 1,466,666 shares of Series A Preferred Stock with a par value of $0.001 per share and a stated value of $375.00 per share. The stated value per share may be increased from time to time in the event dividends on the Series A are paid-in-kind (“PIK dividends”) pursuant to the Series A Certification of Designation (the “Series A Certificate”). On August 1, 2022, pursuant to the Purchase Agreement, the Company issued all of the authorized Series A Preferred Stock to Pepsi for cash consideration aggregating $550.0 million, excluding issuance costs. The Series A Preferred Stock was issued concurrently with the execution of the Distribution Agreement and the Transition Agreement. The Company determined that the aggregate fair value of the Series A Preferred Stock on the issuance date was $832.5 million, or $567.61 per share. Accordingly, the Series A Preferred Stock was recorded at that amount, net of issuance costs of $8.0 million, in the Company’s consolidated balance sheets, and consolidated statements of changes in stockholders’ equity and mezzanine equity.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
The Company engaged a third-party valuation firm to assist in determining the fair value of the 1,466,666 shares of Series A Preferred Stock as of the date of issuance. The valuation of the Series A Preferred Stock represents a non-recurring fair value measurement. The Company used a Monte Carlo simulation model to determine the fair value of the Series A Preferred Stock on August 1, 2022. The Monte Carlo simulation utilized multiple level 2 input variables to determine the value of the Series A Preferred Stock including a volatility rate of 45.0%, risk free interest rate of 2.7%, 5.0% dividend rate, the closing price of the Company’s common stock on the issuance date of $98.87 (pre- three-for-one split), a debt discount rate of 12.5% and a discount for lack of marketability attributed to the registration period of the underlying stock. The selected historical volatility was based on Celsius and a certain peer group. The risk-free interest rate was based on the U.S. STRIPS Rate with a corresponding term as of issuance date. The 5.0% dividend rate is consistent with the provisions of the Series A Preferred Stock and with the Company’s past payments of dividends made in cash. The debt discount rate was based on estimated credit analysis and corresponding market yields as of the issuance date. The Company applied a nominal discount for lack of marketability with respect to the assumed registration period of the underlying shares.
Mezzanine Classification
The Series A Preferred Stock is redeemable in the event of a change in control as defined in the Series A Certificate. ASC 480, Distinguishing Liabilities from Equity ("ASC 480"), specifically ASC 480-10-S99-3A, requires preferred securities that are redeemable for cash or other assets to be classified outside of permanent equity if they are redeemable (i) at a fixed or determinable price on a fixed or determinable date, (ii) at the option of the holder, or (iii) upon the occurrence of an event that is not solely within the control of the issuer. Preferred securities that are mandatorily redeemable are required to be classified by the issuer as liabilities whereas under ASC 480 an issuer should classify a preferred security whose redemption is contingent on an event not entirely in control of the issuer as mezzanine equity. The Series A is not considered mandatorily redeemable other than in the event of a change of control, and a change in control is not solely in control of the Company. Accordingly, the Company determined that mezzanine treatment is appropriate for the Series A and has presented it as such in the condensed consolidated balance sheets and condensed consolidated statements of changes in stockholders’ equity and mezzanine equity, as of March 31, 2025 and December 31, 2024.
Pursuant to the Purchase Agreement, Pepsi, together with its affiliates, has certain rights and is also subject to various restrictions with respect to its ownership of the Company’s outstanding common stock on an as-converted basis, through purchases of the Company’s common stock in the open market and the accumulation of PIK dividends. Additionally, pursuant to the Purchase Agreement, Pepsi has the right to designate one nominee for election to the Board for so long as Pepsi (together with its affiliates) beneficially owns at least approximately 11.0 million shares of the Company’s outstanding common stock on an as-converted basis. Notwithstanding that the Series A is not currently convertible into common stock, the Purchase Agreement provides that Pepsi is deemed to beneficially own the underlying shares of common stock for purposes of its rights under the Purchase Agreement. In August 2022, the Company expanded the number of Board seats in connection with the election of a Pepsi representative to the Board.
Liquidation Preference
The Series A ranks, with respect to distribution rights and rights on liquidation, winding-up and dissolution, (i) senior and in priority of payment to the Company’s common stock, (ii) senior to any class or series of capital stock of the Company expressly designated as ranking junior to the Series A, (iii) on parity with any class or series of capital stock of the Company expressly designated as ranking on parity with the Series A, and (iv) junior to any class or series of capital stock of the Company expressly designated as ranking senior to the Series A. The aggregate liquidation preference of the Series A was $550.0 million as of both March 31, 2025 and December 31, 2024.
Voting
The Series A confers no voting rights, except as otherwise required by applicable law, and with respect to matters that adversely change the powers, preferences, privileges, rights or restrictions given to the Series A or provided for its benefit, or would result in securities that would be senior to or pari passu with the Series A. As described above, Pepsi has a contractual right to representation on the Board, subject to maintaining certain ownership thresholds.
Stock Split
As a result of the forward stock split, the conversion ratio for Series A Preferred Stock, initially set at five-for-one, was adjusted to fifteen-for-one. The adjustment maintains the proportional interests of Series A stockholders post-split. The revised conversion ratio, reflecting the impact of the forward stock split, became effective on the split's effective date.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
Dividends
The Series A entitles the holder to cumulative dividends, which are payable quarterly in arrears either in cash, in-kind, or a combination thereof, at the Company’s election (“Regular Dividends”). Regular Dividends accrue on each share of Series A at the rate of 5.00% per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly Regular Dividends, shares of Series A also entitle the holder to participate in any dividends paid on the Company’s common stock on an as-converted basis. The Company declared and paid $6.8 million and $6.8 million in Regular Dividends on the Series A, which amounted to $4.62 and $4.66 per share of Series A for the three months ended March 31, 2025 and 2024, respectively. There were no cumulative undeclared dividends on the Series A at March 31, 2025. In addition, there were no dividends issued to common shareholders for the three months ended March 31, 2025 or 2024.
Redemption
Subject to certain conditions set forth in the Series A Certificate, Series A may be redeemed at a price per share of Series A equal to the sum of (i) the stated value of such share of Series A as of the applicable redemption date, plus (ii) without duplication, all accrued and unpaid dividends previously added to the stated value of such share of Series A, and all accrued and unpaid dividends per share of Series A through such redemption date (the “Redemption Price”).
Company’s Optional Redemption
At any time from and after the earlier of (i) August 1, 2029, if the ten-day volume weighted average price of the Company’s common stock (the “Ten-Day VWAP”) does not exceed the conversion price on the date immediately prior to the date the Company delivers a redemption notice to the holders, and (ii) the cancellation of the Distribution Agreement by the Company, the Company has the right to redeem all (and not less than all) of the then-outstanding shares of Series A at the Redemption Price. In the event of the Company's optional redemption, the Company shall affect such redemption by paying the entire Redemption Price on or before the date that is thirty days after the delivery of the Company’s redemption notice and by redeeming all the shares of Series A on such date.
Change in Control Redemption
In the event of a change in control, as defined by the following scenarios, the Company (or its successor) shall redeem all (and not less than all) of the then-issued and outstanding shares of Series A: (i) a sale or transfer, directly or indirectly, of all or substantially all of the assets of the Company in any transaction or series of related transactions (other than sales in the ordinary course of business); (ii) any merger, consolidation or reorganization of the Company with or into any other entity or entities as a result of which the holders of the Company’s outstanding capital stock (on a fully-diluted basis) immediately prior to the merger, consolidation or reorganization no longer represent at least a majority of the voting power of the surviving or resulting Company or other entity; or (iii) any sale or series of sales, directly or indirectly, beneficially or of record, of shares of the Company’s capital stock by the holders thereof which results in any person or group of affiliated persons owning capital stock holding more than 50% of the Company's voting power.
Upon a change in control and redemption, each Series A holder will receive, an amount equal to the greater of (A) the Redemption Price in cash and (B) the cash and/or other assets (including securities) such holder would have received if each share of Series A were converted into a number of shares of common stock equal to the then-applicable conversion ratio and participated in such transaction resulting in such change of control as of the close of business on the business day immediately prior to the effective date of such transaction.
If the Company or its successor shall not have sufficient funds legally available under the Nevada law governing distributions to stockholders to redeem all outstanding shares of Series A, then the Company shall (A) redeem, pro rata among the holders, a number of shares of Series A equal to the number of shares of Series A that can be redeemed with the maximum amount legally available for the redemption, and (B) redeem all remaining shares of Series A not redeemed because of the foregoing limitations at the applicable change of control Redemption Price as soon as practicable after the Company (or its successor) is able to make such redemption out of assets legally available for the purchase of such shares of Series A. The inability of the Company (or its successor) to make a redemption payment for any reason shall not relieve the Company (or its successor) from its obligation to affect any required redemption when, as and if permitted by applicable law.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
Holder Right to Request Redemption
On each of August 1, 2029, August 1, 2032, and August 1, 2035, the majority holders of the Series A have the right, upon no less than six months prior written notice to the Company, to request that the Company redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price.
In the event of a holder-optional redemption, the Redemption Price will be payable, and the Company shall redeem the shares in three equal installments. These installments would commence on August 1, 2029, August 1, 2032, or August 1, 2035, as applicable, and in each case on the fifteenth- and thirtieth-month anniversary thereafter. On each redemption date for a holder-optional redemption, the Company will redeem shares of Series A on a pro rata basis according to the number of shares owned by each holder. The number of outstanding shares will be determined by dividing (i) the total number of shares of Series A Preferred Stock outstanding immediately prior to such redemption date by (ii) the number of remaining redemption dates (including the redemption date to which such calculation applies).
If, on any redemption date, legal constraints under the Nevada law governing distributions to stockholders or the terms of any indebtedness of the Company to financial institutions prevents the Company from redeeming all shares of Series A, the Company will ratably redeem the maximum number of shares that it may legally redeem, and will redeem the remaining shares as soon as it may lawfully do so.
Should any shares of Series A scheduled for redemption on a redemption date remain unredeemed for any reason on such redemption date, the following will occur: from the redemption date to the fifteen-month anniversary of such redemption date, the dividend rate with respect to such unredeemed share will automatically increase to 8% per annum. From such fifteenth-month anniversary to the thirtieth-month anniversary of such redemption date, the dividend rate with respect to such unredeemed share will automatically increase to 10% per annum. After such thirtieth-month anniversary of such redemption date, the dividend rate with respect to any such unredeemed share will automatically increase to 12% per annum, in each case until such share is duly redeemed or converted.
Conversion
The shares of Series A may be converted into shares of the Company’s common stock pursuant to the Series A Certificate either at the option of the Company or subject to an automatic conversion as discussed below. The Series A was issued with a conversion price of $25 which is potentially subject to adjustment pursuant to the Series A Certificate. The conversion ratio is calculated as the quotient of (a) the sum of (x) the stated value of such share of Series A as of the applicable conversion date, plus (y) all accrued and unpaid dividends previously added to the stated value of such share of Series A, and without duplication, all accrued and unpaid dividends per share of Series A through the applicable conversion date; divided by (b) the conversion price as of the conversion date. As of March 31, 2025, the conversion ratio of the Series A into common stock was one to fifteen. At March 31, 2025, approximately 22.0 million shares of common stock were issuable upon conversion of the Series A Preferred Stock.
As of March 31, 2025, the Series A was not probable of becoming redeemable, as the most likely method of settlement is through conversion which is likely to occur before the holder's right to request redemption becomes exercisable.
Company Optional Conversion
At any time from and after August 1, 2029, provided the Ten-Day VWAP immediately prior to the date the Company delivers a conversion notice to the holders of Series A exceeds the conversion price, the Company may elect to convert all, but not less than all, of the outstanding shares of Series A into shares of the Company’s common stock.
Automatic Conversion
The Series A will convert automatically into shares of the Company’s common stock upon the occurrence of any of the following, each an “Automatic Conversion Event”:
•Any date from and after the valid termination of the Distribution Agreement by the Company or Pepsi, if the Ten-Day VWAP immediately preceding such date exceeds the conversion price of such share as of such date.
•Any date from and after August 1, 2028, on which (x) the Company’s products meet a market share requirement during a specified period (as defined in the Distribution Agreement) and (y) the Ten-Day VWAP immediately prior to such date exceeds the conversion price of such share as of such date. In the case of an Automatic Conversion Event, each share of Series A then outstanding shall be converted into the number of shares of common stock equal to the conversion ratio of such share in effect as of the automatic conversion date. The occurrence of an Automatic Conversion Event will terminate any right of the holder to receive a redemption at their request even if such request had already been submitted, provided that the Series A Preferred shares had not already been redeemed.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
12. STOCK-BASED COMPENSATION
As of March 31, 2025, there were 23.4 million shares of common stock available for issuance under the Company's 2015 Stock Inventive Plan (the "2015 Plan"). The 2015 Plan expired in April 2025, and the Company is seeking stockholder approval of a new plan at the 2025 annual meeting of stockholders. No further awards can be granted under the 2015 Plan.
A summary of the Company’s restricted stock units ("RSUs") and PSUs for the three months ended March 31, 2025 and 2024 is presented in the following table:
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | |
| 2025 | | 2024 | | |
| RSUs/PSUs (000’s) | | Weighted Average Grant Date Fair Value | | RSUs/PSUs (000’s) | | Weighted Average Grant Date Fair Value | | | | |
Unvested at beginning of period | 1,021 | | $ | 45.09 | | | 1,341 | | $ | 26.43 | | | | | |
| | | | | | | | | | | |
Granted | 1,074 | | 26.41 | | | 275 | | 78.22 | | | | | |
Vested | (249) | | 44.09 | | | (510) | | 22.89 | | | | | |
Forfeited and cancelled | (10) | | 50.81 | | | (12) | | 23.23 | | | | | |
Unvested at end of period | 1,836 | | $ | 34.27 | | | 1,094 | | $ | 41.21 | | | | | |
Performance-based Stock Awards
A summary of PSU awards granted during the three months ended March 31, 2025, is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Grant Date | | Shares (000’s) | | Performance Period | | Metrics | | Grant Date Fair Value | | | | |
| | | | | | | | | | | | |
March 1, 2025 | | 142 | | 2025-2027 | | Revenue rTSR | | Revenue - $25.69 rTSR - $36.61 | | | | |
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
13. SEGMENT REPORTING
The Company operates in multiple geographical regions and functions as a single operating segment because its operations and strategies are centrally designed and executed, and remain significantly similar across these regions. The CODM, who is the Company’s Chief Executive Officer, evaluates operating results and allocates resources on a consolidated basis due to the significant economic interdependencies between the Company's geographical operations. As a result, the Company is managed as a single operating segment and has a single reportable segment. The primary financial measure reviewed by the CODM is net income.
The following table reflects certain financial data for the Company's single reportable segment:
| | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | | | |
| 2025 | | 2024 | | | | | | | | |
Revenue | $ | 329,276 | | | $ | 355,708 | | | | | | | | | |
Cost of sales (excluding freight) | (142,476) | | | (159,546) | | | | | | | | | |
Freight | (14,427) | | | (13,955) | | | | | | | | | |
Gross profit | 172,373 | | | 182,207 | | | | | | | | | |
| | | | | | | | | | | |
Selling and marketing expenses | (80,898) | | | (75,838) | | | | | | | | | |
General and administrative expenses | (39,444) | | | (23,179) | | | | | | | | | |
Other income | 8,962 | | | 9,271 | | | | | | | | | |
Net income before provision for income taxes | $ | 60,993 | | | $ | 92,461 | | | | | | | | | |
| | | | | | | | | | | |
Provision for income taxes | (16,574) | | | (14,650) | | | | | | | | | |
Net income | $ | 44,419 | | | $ | 77,811 | | | | | | | | | |
14. COMMITMENTS AND CONTINGENCIES
Legal
SEC Inquiry
Beginning in January 2021, the Company received formal and informal requests from the SEC Division of Enforcement, seeking information in connection with a non-public, fact-finding inquiry. On January 17, 2025, without admitting to or denying the SEC’s findings, the Company reached a settlement with the SEC concerning alleged reporting, books and records, internal accounting controls, and disclosure controls and procedures violations. The Company paid a $3.0 million civil penalty during the three months ended March 31, 2025, and the investigation is now concluded with respect to the Company.
Derivative Actions Related to 2022 Restatement
Between January 11, 2023, and April 11, 2024, several derivative actions were filed, purportedly on behalf of the Company, naming as defendants certain of the Company’s present and former executive officers and directors and concerning allegedly false and misleading statements or omissions made between August 12, 2021 and March 1, 2022, which were alleged to have artificially inflated the Company’s stock price and caused the Company to restate, in 2022, its previously issued financial statements as of and for the year ended December 31, 2021.
The first such derivative action was filed on January 11, 2023, in the U.S. District Court for the District of Nevada, by stockholder Doreen R. Lampert (the “Lampert Derivative Action”). The Company was named as a nominal defendant. The Lampert Derivative Action asserted claims for (i) breach of fiduciary duty, (ii) unjust enrichment, and (iii) violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10b-5 promulgated thereunder.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
A second derivative action was filed on May 19, 2023, in the U.S. District Court for the Southern District of Florida, by stockholder Jennifer Hammond (the “Hammond Derivative Action”). The Hammond Derivative Action asserted claims for (i) breach of fiduciary duty, (ii) aiding and abetting breach of fiduciary duty, (iii) unjust enrichment, (iv) waste of corporate assets, and (v) violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder.
A third derivative action was filed on July 10, 2023, in the District Court for the Eighth Judicial District in Clark County, Nevada, by stockholder Nicholas R. Ingrao (the “Ingrao Derivative Action”). The Ingrao Derivative Action asserted claims for (i) breach of fiduciary duty and (ii) unjust enrichment.
A fourth derivative action was filed on July 12, 2023, in the U.S. District Court for the Southern District of Florida, by stockholder Dana Hepworth (the “Hepworth Derivative Acton”). The Hepworth Derivative Action asserted claims for (i) breach of fiduciary duty, (ii) aiding and abetting breach of fiduciary duty, (iii) unjust enrichment, (iv) waste of corporate assets, and (v) violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder.
On March 11, 2024, the Hammond Derivative Action and the Hepworth Derivative Action were voluntarily dismissed and, on April 11, 2024, a single complaint containing substantially similar allegations as those dismissed actions was filed in the U.S. District Court for the District of Nevada, by the same stockholders (the “Hammond and Hepworth Derivative Action”).
On December 2, 2024, the parties to the Lampert Derivative Action, the Ingrao Derivative Action, and the Hammond and Hepworth Derivative Action (collectively, the “Derivative Actions”) executed a Stipulation and Agreement of Settlement (the “Stipulation of Settlement”), which set out the terms of a global settlement of the Derivative Actions.
On December 13, 2024, the plaintiff in the Ingrao Derivative Action filed an Unopposed Motion for Preliminary Approval of Proposed Shareholders Derivative Settlement. On April 3, 2025, the Court in the Ingrao Derivative Action entered a final order approving the settlement. The only monetary component of the Stipulation of Settlement is a $1.0 million fee and expense award to counsel for plaintiffs in the Derivative Actions, which is reflected in accrued expenses in the condensed consolidated balance sheet as of March 31, 2025. In accordance with the final order approving the settlement, the Ingrao Derivative Action was dismissed on April 3, 2025. The Court in the Lampert Derivative Action dismissed that action on April 10, 2025, following a joint request of the parties. On April 8, 2025, the parties filed a proposed order to dismiss the Hammond and Hepworth Derivative Action.
Securities Litigation Concerning the PepsiCo Inc. Distribution Agreement
The Company and individual executives were named as defendants in two putative securities class actions, both filed in the U.S. District Court for the Southern District of Florida and concerning, among other things, allegedly false and misleading statements or omissions concerning the Company’s distribution agreement with Pepsi and the Company’s growth. The first putative securities class action was filed on November 22, 2024. The complaint asserts claims for violations of Section 10(b) of the Exchange Act, Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. The second putative securities class action was filed on January 14, 2025. The complaint also asserts claims for violations of Section 10(b) of the Exchange Act, Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. On March 3, 2025, the Court issued an order consolidating the two putative securities class actions and appointing Lead Plaintiff and Lead Counsel. Lead Plaintiff filed an Amended Complaint on April 25, 2025, naming the Company, its CEO, CFO, and Chief of Staff as defendants. The Amended Complaint asserts claims for violations of Section 10(b) of the Exchange Act, Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act. The Amended Complaint was filed on behalf of stockholders who purchased or otherwise acquired shares of the Company’s stock between May 9, 2023 and November 5, 2024. The Court has ordered that the Company shall file its response on or before June 13, 2025.
The Company has been named as a nominal defendant and certain of its current and former executive officers and directors have been named as defendants in derivative actions pending in federal and state court in Nevada, concerning, among other things, allegedly false and misleading statements or omissions concerning the Company’s distribution agreement with Pepsi and the Company’s growth. The first of these derivative actions was filed on December 16, 2024, in the U.S. District Court of the District of Nevada, by purported stockholder Kurt Dobler (the "Dobler Derivative Action"). The Company was named as a nominal defendant. The complaint asserts claims for (i) violations of Section 14(a) of the Exchange Act, (ii) breach of fiduciary duty, (iii) unjust enrichment, (iv) waste of corporate assets, (v) gross mismanagement, (vi) abuse of control, and (vii) contribution under Section 10(b) and 21D of the Exchange Act, solely against the Company’s CEO and CFO. The second of these derivative actions was filed on January 31, 2025, in the U.S. District Court of the District of Nevada, by purported stockholder Mark Stoyanoff (the “Stoyanoff Derivative Action”). The Company was named as a nominal defendant. The complaint asserts claims for (i) breach of fiduciary duty, (ii) aiding and abetting breach of fiduciary duty, (iii) unjust enrichment, (iv) violations of Section 14(a) of the Exchange Act and Rule 14a-9, (v) abuse of control, and (vi) waste of corporate assets. The Dobler Derivative Action and the Stoyanoff Derivative Action were consolidated on March 5, 2025 (the “Consolidated Derivative Action”). The third of these derivative actions was filed on February 7, 2025, in District Court, Clark County, Nevada, by purported stockholder Shadia Khan Sunny. The complaint asserts claims for (i) breach of fiduciary duty, (ii) unjust enrichment, (iii) abuse of control, and (iv) waste of corporate assets. The fourth of these derivative actions was filed on February 11, 2025, also in District Court, Clark County, Nevada, by purported stockholder David Murphy. The complaint asserts claims for (i) breach of fiduciary duty, and (ii) unjust enrichment. The fifth of these derivative actions was filed on March 31, 2025, also in District Court, Clark County, Nevada, by purported stockholder Suzanne Flannery. The complaint asserts claims for (i) breach of fiduciary duty, and (ii) unjust enrichment.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
The Company believes that the claims asserted in the foregoing putative securities class actions and derivative actions are without merit and that the likelihood of loss is remote. However, the ultimate outcome of these actions may differ materially from the Company’s current expectations, and the Company is unable to reasonably estimate a range of losses at this time. The Company will vigorously defend itself and its current and former executive officers and directors.
California Consumer Class Action
On January 22, 2025, the Company and certain individuals were named as defendants in a putative class action filed in the U.S. District Court for the Central District of California. The complaint alleges, on behalf of a putative nationwide class of all Celsius purchasers, that plaintiff and other class members were misled regarding the alleged financial relationship between Celsius and the individual defendants, who allegedly promoted the Company’s products on social media. The complaint asserts claims for (i) violation of California’s Consumers Legal Remedies Act and Unfair Competition Law, (ii) unjust enrichment, and (iii) negligent misrepresentation.
The Company believes that the claims asserted in this putative class action are without merit and that the likelihood of loss is remote. However, the ultimate outcome of these actions may differ materially from the Company’s current expectations, and the Company is unable to reasonably estimate a range of losses at this time. The Company will vigorously defend itself against this allegation.
Strong Arm Productions
On May 4, 2021, Plaintiffs Strong Arm Productions USA, Inc., Tramar Dillard p/k/a Flo Rida, and D3M Licensing Group, LLC filed a lawsuit against the Company in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida. Plaintiffs asserted that the Company breached two endorsement and licensing agreements that were entered into, between Plaintiffs and the Company in 2014 and 2016. Plaintiffs alleged the Company had reached certain revenue and sales benchmarks set forth in the 2014 agreement that entitled them to receive 2.25 million shares (as adjusted for the forward stock split) of the Company's common stock. In addition, the Plaintiffs claimed they were entitled to receive unspecified royalties under the 2016 agreement.
A jury trial commenced on this matter on January 10, 2023. On January 18, 2023, the jury rendered a verdict against the Company for $82.6 million in compensatory damages. On April 27, 2023, the court denied the Company’s post-trial motions which sought (i) dismissal of the case notwithstanding the verdict based on the plain language of the contracts at issue; (ii) in the alternative, granting a new trial; or (iii) in the alternative, reducing the award of damages to $2.1 million, which reflects the Company’s stock price on the date that the jury found the relevant revenue and sales benchmarks at issue were met.
The Company believed that the jury verdict was not supported by the facts of the case or applicable law and was the result of significant trial error, and there were strong grounds for appeal. The Company filed a notice of appeal to the Fourth District Court of Appeal (“DCA”) for the State of Florida on February 21, 2023. By order dated December 11, 2024, the Fourth DCA granted the Company’s requested relief, in part, by vacating the amount of the jury’s verdict and directing a retrial on that issue, while affirming the jury’s finding of liability. On December 19, 2024, the Company requested the DCA rehear the appeal, and on February 6, 2025, the DCA denied that rehearing request. On February 28, 2025, the Company filed a Notice to Invoke Discretionary Jurisdiction of the Florida Supreme Court. The Company intends to continue to vigorously challenge the judgment through the appeal processes.
As a result of the February 6, 2025 decision, the Company has estimated a range of possible outcomes between $55.9 million and $97.6 million, inclusive of interest and fees. The Company accrued a liability at the low end of the range in the amount of $55.9 million, reflected in accrued expenses in the condensed consolidated balance sheet as of March 31, 2025. The ultimate amount of the judgement that the Company may be required to pay will also include interest incurred between March 31, 2025 and the payment date, which could be materially different than the amount the Company has accrued. The Company cannot predict or estimate the duration or ultimate outcome of this matter.
Eniva Trademark Litigation Concerning Vibe-Formative Marks
On March 20, 2025, the Company filed a declaratory judgment action in the U.S. District Court for the District of Minnesota against Eniva USA, Inc. (“Eniva”), seeking a declaration that the Company's use and registration of various VIBE-formative marks do not infringe Eniva’s trademark rights. The dispute follows proceedings filed by Eniva at the Trademark Trial and Appeal Board, alleging that the Company's marks are likely to cause confusion with its own VIBE-registered mark used on liquid dietary supplements.
On April 10, 2025, Eniva filed its answer and counterclaims, asserting, among other things, that the Company's use of the VIBE-formative marks constitutes trademark infringement under federal and state law, false designation of origin, and unfair competition. Eniva further seeks an order declaring that the Company is not entitled to register its marks. Eniva seeks injunctive relief, damages, cancellation of the Company’s trademark applications, and attorneys’ fees.
Celsius Holdings, Inc.
Notes to the Condensed Consolidated Financial Statements (Unaudited)
March 31, 2025
(Tabular dollars in thousands, except per share amounts)
The Company believes Eniva’s claims are without merit and the likelihood of loss is remote. However, the ultimate outcome of these actions may differ materially from the Company’s current expectations, and the Company is unable to reasonably estimate a range of losses at this time. The Company will vigorously defend its rights to use its intellectual property.
Commitments
As of March 31, 2025, the Company had purchase commitments to third parties of $518.7 million. These purchase obligations are primarily related to third-party suppliers and have arisen through the normal course of business. Contracts that specify that the Company will purchase all or a portion of its requirements of a specific product or service from a supplier, but do not include a fixed or minimum quantity, are excluded from the obligations quantified above.
As of March 31, 2025, the Company had long term contractual obligations aggregating to approximately $25.9 million, which related primarily to suppliers, sponsorships and other related marketing activities.
15. SUBSEQUENT EVENTS
Acquisition of Alani Nutrition LLC
On April 1, 2025, the Company completed its acquisition of Alani Nu. The transaction was executed pursuant to the Membership Interest Purchase Agreement dated February 20, 2025 (the “Alani Nu Purchase Agreement”). The acquisition aligns with the Company's focus on the performance energy and health-focused wellness segments. The combination is consistent with the Company’s strategy of leveraging operational synergies across sales, marketing, and distribution channels.
Under the terms of the Alani Nu Purchase Agreement, the Company acquired all of the issued and outstanding membership interests of Alani Nu from the Sellers. Total consideration consisted of the following:
•$1,275.0 million in cash, subject to customary post-closing adjustments;
•22,451,224 shares of Celsius common stock, subject to a lock-up agreement that restricts the sale or transfer of the Company's common stock, with one-third of the common stock released from restrictions on each April 1, 2026, October 1, 2026 and April 1, 2027; and
•up to $25.0 million in cash consideration, payable only if net sales of Alani Nu’s products meet or exceed an agreed target for 2025 as set forth in the Alani Nu purchase agreement.
To fund part of the cash portion of the purchase price, on April 1, 2025, the Company, certain of the Company's subsidiaries, the lenders and issuing banks from time to time party thereto and UBS AG, Stamford Branch, as administrative agent and collateral agent, entered into a Credit Agreement (the “Credit Agreement”). The Credit Agreement provides for a term loan facility in an aggregate principal amount of up to $900.0 million, which was fully drawn at closing to fund a portion of the cash consideration, and a revolving credit facility in an aggregate principal amount of up to $100.0 million. The remaining cash consideration was funded with existing cash on hand.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
When used in this Quarterly Report on Form 10-Q (this "Report"), unless otherwise indicated, the terms the “Company,” “Celsius,” “we,” “us” and “our” refer to Celsius Holdings, Inc. and its subsidiaries.
Cautionary Note Regarding Forward-Looking Statements
This Report contains forward-looking statements that are based on the current expectations of our Company and management about future events within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA"), Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and are made in reliance of the safe harbor protections provided thereunder. While we have specifically identified certain information as being forward-looking in the context of its presentation, we caution you that all statements contained in this Report that are not clearly historical in nature, including statements regarding our ability to successfully integrate Alani Nutrition LLC ("Alani Nu"); the strategic investment by and long term partnership with PepsiCo, Inc. ("Pepsi"); anticipated financial performance; management’s plans and objectives for international expansion and future operations globally; the successful development, commercialization, and timing of new products; business prospects; outcomes of regulatory proceedings; market conditions; the current and future market size for existing or new products; any stated or implied outcomes with regards to the foregoing; and other matters are forward-looking.
Without limiting the generality of the preceding sentences, any time we use the words “expects,” “intends,” “will,” “anticipates,” “believes,” “confident,” “continue,” “propose,” “seeks,” “could,” “may,” “should,” “estimates,” “forecasts,” “might,” “goals,” “objectives,” “targets,” “planned,” “projects,” and, in each case, their negative or other various or comparable terminology, and similar expressions, we intend to clearly express that the information deals with possible future events and is forward-looking in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include, without limitation:
•Our ability to successfully integrate Alani Nu or other businesses that we may acquire;
•Our ability to achieve the benefits that we expect to realize as a result of the acquisition of Alani Nu;
•The potential negative impact that we could realize as a result of the acquisition of Alani Nu;
•Liabilities of Alani Nu that are not known to us;
•Our ability to maintain a strong relationship with Pepsi or any of our other distributors;
•The impact of the consolidation of retailers, wholesalers and distributors in the industry;
•Our reliance on key distributor partnerships;
•Our ability to maintain strong relationships with co-packers to manufacture our products;
•Our ability to maintain strong relationships with our customers;
•Our failure to accurately estimate demand for our products;
•The impact of increases in cost or shortages of raw materials or increases in costs of co-packing;
•Our ability to successfully achieve the benefits of our recent acquisition of Big Beverages Contract Manufacturing L.L.C. ("Big Beverages"), a co-packer;
•Our ability to successfully estimate and/or generate demand through the use of third-parties, including celebrities, social media influencers, and others, may expose us to risk of negative publicity, litigation, and/or regulatory enforcement action;
•The impact of additional labeling or warning requirements or limitations on the marketing or sale of our products;
•Our ability to successfully expand outside of the United States (“U.S.”) and the impact of U.S. and international laws, including export and import controls and other risk exposure;
•Our ability to successfully complete or manage strategic transactions, successfully integrate and manage our acquired businesses, brands or bottling operations, or successfully realize a significant portion of the anticipated benefits of our joint ventures or strategic relationships;
•Our ability to protect our brand, trademarks, proprietary rights, and our other intellectual property;
•The impact of internal and external cyber-security threats and breaches;
•Our ability to comply with data privacy and personal data protection laws;
•Our ability to effectively manage future growth;
•The impact of global or regional catastrophic events on our operations and ability to grow;
•The impact of any actions by the U.S. Food and Drug Administration (the "FDA") regarding the manufacture, composition/ingredients, packaging, marketing/labeling, storage, transportation, and/or distribution of our products;
•The impact of any actions by the Federal Trade Commission (the "FTC") on our advertising;
•Our ability to effectively compete in the functional beverage product industry and the strength of such industry;
•The impact of changes in consumer product and shopping preferences;
•The impact of changes in government regulation and our ability to comply with existing regulation concerning energy drinks;
•Other statements regarding our future operations, financial condition, prospects and business strategies; and
•Those factors contained in this Report under the heading, "Risk Factors".
Forward-looking statements and information involve risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such statements, including without limitation, the risks and uncertainties disclosed or referenced in Part I, Item 1A Risk Factors of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the "2024 Annual Report"). Therefore, caution should be taken not to place undue reliance on any such forward-looking statements. Much of the information in this Report that looks toward future performance is based on various factors and important assumptions about future events that may or may not actually occur. As a result, our operations and financial results in the future could differ materially and substantially from those we have discussed in the forward-looking statements included in this Report. We assume no obligation (and specifically disclaim any such obligation) to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Our Business
Executive-Level Overview
Celsius is a functional energy drink company operating in the United States and internationally. This product is available in two convenient forms: ready-to-drink and an on-the-go portable powder form. Additionally, we offer our Celsius Essentials line, featuring 16-ounce cans enriched with aminos. In 2025, we introduced CELSIUS® Hydration, a line of zero-sugar hydration powders, featuring electrolytes in a variety of fruit-forward flavors. Our product range is widely available across the U.S. and in select territories in Canada in various retail outlets, including grocery stores, natural product stores, convenience stores, fitness centers, mass retailers, vitamin specialty stores, and through online e-commerce platforms. Moreover, our products are offered in select markets in Europe, the Middle East and the Asia-Pacific region as we have continued to expand our global presence.
We engage in various aspects of developing, manufacturing, processing, marketing, selling, and distributing Celsius, Celsius Essentials, Celsius On-The-Go Powder, and Celsius Hydration. Our operational model strategically relies primarily on co-packers for the manufacture and supply of our products, leveraging their specialized expertise and scalable production capabilities. Additionally, we utilize our in-house manufacturing facility to complement our strategic use of co-packers. This approach allows us to maintain flexibility in responding to market demands and to focus our resources on innovation, marketing, and expanding our distribution channels. We continuously assess and work to optimize our supply chain to ensure quality, consistency and timely delivery to our customers.
On August 1, 2022, we entered into a long-term distribution agreement with Pepsi, making them our primary distributor in the U.S. and leveraging the right of first offer to facilitate our expansion into Canada. This agreement also helps to enable our potential entry into additional international markets and new distribution channels with Pepsi. In connection with our relationship with Pepsi, we terminated certain previous distributor agreements and shifted certain distribution rights to Pepsi.
Impact of Tariffs and Macroeconomic Trends
We continue to monitor macroeconomic conditions and global trade developments, including inflation in key input costs, recently implemented tariffs, and the potential for additional or modified tariffs or export controls. On April 2, 2025, the U.S. presidential administration announced new tariffs, which, along with evolving global trade policies, may contribute to increased supply chain complexity, commodity cost volatility, and broader economic uncertainty. While these developments could pressure our cost structure, based on our current analysis, we do not currently expect them to have a material adverse impact on our results of our operations for the remainder of fiscal year 2025. We are actively evaluating the potential implications of how the evolving tariff policies may impact customer and consumer behavior and the results of our operations.
Acquisition of Alani Nutrition LLC
On February 20, 2025, we announced that we had entered into a membership interest purchase agreement to acquire Alani Nu for a total consideration comprising (i) $1,275.0 million in cash, subject to adjustment as set forth in the purchase agreement, (ii) an aggregate of 22,451,224 shares of our common stock and (iii) up to $25.0 million in additional cash consideration, payable only if net sales of Alani Nu’s products meet or exceed an agreed target for 2025. On April 1, 2025, we completed the acquisition and simultaneously entered into a debt financing arrangement. The financing package included a $900.0 million Term Loan B and a $100.0 million Revolving Credit Facility.
Results of Operations
Three months ended March 31, 2025 compared to three months ended March 31, 2024
Revenue
For the three months ended March 31, 2025, revenue was approximately $329.3 million, a decrease of $26.4 million, or 7.4%, from $355.7 million for the three months ended March 31, 2024.
For the three months ended March 31, 2025, revenue in North America declined by $33.0 million, or 9.7%, compared to the three months ended March 31, 2024. The prior-year quarter benefited from the early launch of our 16oz Celsius Essentials line and the implementation of several promotional activations across key retail and convenience channels at the beginning of the quarter. In contrast, similar promotional efforts during the current-year quarter were launched toward the end of the period. This timing difference, along with the initial launch of the 16oz Celsius Essentials line in the prior year, contributed to the year-over-year sales decline. Additionally, we experienced lower velocity in the current quarter and were fully impacted by the increased promotional allowances and incentive program established in the prior year with our primary distributor.
European revenues for the three months ended March 31, 2025 were approximately $18.7 million, representing an increase of $4.5 million, or 31.9%, from the three months ended March 31, 2024. Other international markets generated approximately $1.8 million in revenue during the three months ended March 31, 2025, with Asia-Pacific revenues contributing an additional $2.2 million for the three months ended March 31, 2025. Total international revenue grew 41% year-over-year, primarily driven by the Company’s continued international expansion. Excluding markets launched in 2024, international revenue increased 9% compared to the prior-year period, reflecting organic growth across existing geographies.
The following table sets forth the amount of revenues by geographical location for the three months ended March 31, 2025 and March 31, 2024:
| | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, | |
(Amounts in thousands) | | 2025 | | 2024 | | | |
| | | | | | | |
North America | | $ | 306,534 | | | $ | 339,512 | | | | |
Europe | | 18,659 | | | 14,142 | | | | |
Asia-Pacific | | 2,244 | | | 675 | | | | |
Other | | 1,839 | | | 1,379 | | | | |
Revenue | | $ | 329,276 | | | $ | 355,708 | | | | |
Gross Profit
For the three months ended March 31, 2025, gross profit decreased by $9.8 million to $172.4 million, a decrease of 5.4% from $182.2 million for the three months ended March 31, 2024. Gross profit margin increased to 52.3% for the three months ended March 31, 2025 from 51.2% for the three months ended March 31, 2024. Gross profit margin improvements resulted from decreases in raw and package material unit costs, partially offset by increased promotional allowances as a percentage of revenue.
Selling, General and Administrative Expenses
Selling, general and administrative expenses ("SG&A") for the three months ended March 31, 2025 were $120.3 million, an increase of $21.3 million or 22% from $99.0 million for the three months ended March 31, 2024.
The changes within SG&A expenses included:
•a $12.1 million increase in administrative expenses related primarily to higher acquisition-related costs, including transaction and legal expenses;
•a $4.9 million increase in employee costs, reflecting our ongoing investments to support growth;
•a $2.8 million increase in marketing investments, driven by initiatives and events aimed at enhancing brand awareness to reflect our commitment to long-term growth, helping to ensure that our brand remains top-of-mind with consumers and well-positioned in an increasingly competitive market; and
•a $1.5 million increase in all other SG&A expenses.
Other Income (Expense)
Total other income for the three months ended March 31, 2025 was $9.0 million, which reflects a decrease of $0.3 million from $9.3 million for the three months ended March 31, 2024. This decrease was primarily attributed to lower interest income earned on cash held in our money market accounts, driven by a decline in market interest rates.
Provision for Income Taxes
For the three months ended March 31, 2025, the Company’s effective tax rate was 27.2%, as compared to 15.8% for the same period in 2024. The increase was primarily driven by a shift in stock-based compensation-related impacts. In the current period, the tax rate was higher than the U.S. federal statutory rate of 21.0% due to disallowed stock-based compensation expense and state income taxes. In the prior-year period, the rate was lower than the statutory rate due to net tax benefits related to stock-based compensation, partially offset by similar disallowed expenses and state taxes.
The Company is subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. The Company’s tax returns for tax years beginning 2020 remain subject to potential examination by the taxing authorities.
Net Income Attributable to Common Stockholders
Net income attributed to common stockholders for the three months ended March 31, 2025 was $34.4 million, representing basic earnings per share of $0.15 based on a basic weighted average of 235.2 million shares outstanding. In comparison, for the three months ended March 31, 2024 the Company's net income attributed to common stockholders was $64.8 million, representing basic earnings per share of $0.28 based on a weighted average of 232.8 million shares outstanding. Diluted earnings per share was $0.15 and $0.27 for the three months ended March 31, 2025 and 2024, respectively.
Liquidity and Capital Resources
General
As of March 31, 2025, we had cash and cash equivalents of approximately $977.3 million and working capital of $993.6 million.
Our primary sources of liquidity are cash flows from operations and our existing cash balances. We believe that cash available from operations, including our cash resources, will be sufficient for our working capital needs, including purchase commitments for raw materials and inventory, increases in accounts receivable and other assets, and purchases of capital assets and equipment for the next twelve months and beyond.
Purchases of inventories, increases in accounts receivable and other assets, equipment purchases (including coolers), advances to certain co-packers and distributors, and payments of accounts payable and income taxes are expected to remain our principal recurring uses of cash and material cash requirements.
On April 1, 2025, we completed the acquisition of Alani Nu for a total consideration comprising (i) $1,275.0 million in cash paid at closing, subject to adjustment as set forth in the purchase agreement, (ii) an aggregate of 22,451,224 shares of our common stock and (iii) up to $25.0 million in additional cash consideration, payable only if net sales of Alani Nu’s products meet or exceed an agreed upon target for 2025.
In connection with our acquisition of Alani Nu, on April 1, 2025, we, together with certain of our subsidiaries as guarantors, the lenders and issuing banks from time to time party thereto and UBS AG, Stamford Branch, as administrative agent and collateral agent, entered into a secured credit agreement (the “Credit Agreement”). The Credit Agreement provides for a term loan facility in an aggregate principal amount of up to $900 million (the “Term Loan Facility”), which was fully drawn to fund a portion of the purchase price for Alani Nu, and a revolving credit facility
in an aggregate principal amount of up to $100 million (the “Revolving Facility”), which may include the issuance of letters of credit in a stated face amount of up to, but not exceeding, $50 million. The Term Loan Facility matures on April 1, 2032, and the Revolving Facility matures on April 1, 2030.
Borrowings under the Credit Agreement bear interest, in the case of the Revolving Facility, (A) at a rate equal to (1) the highest of (w) the U.S. prime rate, (x) the Federal Funds Rate plus 0.5%, (y) the sum of the benchmark rate for an interest period of one month plus 1.00%, and (z) 1.00%, plus (2) a margin of 2.0% in the case of alternate base rate loans and (B) a rate equal to term SOFR or EURIBOR rate plus a margin of 3.0% in the case of benchmark rate loans and, in the case of the Term Loan Facility, (A) at a rate equal to (1) the highest of (w) the U.S. prime rate, (x) the Federal Funds Rate plus 0.5%, (y) the sum of the benchmark rate for an interest period of one month plus 1.00%, and (z) 1.00%, plus (2) a margin of 2.25% in the case of alternate base rate loans and (B) a rate equal to term SOFR or EURIBOR plus a margin of 3.25% in the case of benchmark rate loans. Subsequent to the delivery of our financial statements for the first full fiscal quarter following our acquisition of Alani Nu, the interest rate margins under the Term Loan Facility and the Revolving Facility will be subject to step-downs based on the first lien net leverage ratio. The applicable interest rate will be adjusted quarterly on a prospective basis based upon the first lien net leverage ratio in accordance with the terms of the Credit Agreement. The Term Loan Facility and Revolving Facility are secured by a first priority security interest in our and the other borrowers’ and guarantors’ cash, accounts receivable, intellectual property, books and records and related assets and certain intellectual property of other subsidiaries.
We believe our current liquidity position, ongoing cash flow from operations, and access to financing facilities, including the Revolving Facility, are sufficient to meet our near-term and long-term obligations, including integration efforts and other strategic investments following the acquisition of Alani Nu.
Cash flows for the three months ended March 31, 2025 and 2024
Cash flows provided by operating activities
Cash flows provided by operating activities totaled $103.4 million for three months ended March 31, 2025, which compares to $134.6 million net cash provided by operating activities for the three months ended March 31, 2024. The $31.2 million decrease was attributable to a decrease in net income and changes in working capital, including the timing of certain payments and strategic inventory management.
Cash flows used in investing activities
Cash flows used in investing activities totaled $6.9 million for three months ended March 31, 2025, compared to cash used in investing activities of $4.5 million for the three months ended March 31, 2024, related to increased purchases of property, plant and equipment.
Cash flows used in financing activities
Cash flows used in financing activities totaled $10.6 million for the three months ended March 31, 2025, compared to $5.9 million for the same period in 2024, representing a $4.7 million increase. The increase was primarily driven by higher repurchases of common stock for tax withholding obligations related to the vesting of stock based compensation awards and by debt issuance costs incurred in connection with the debt financing arranged for the Alani acquisition, and decreased proceeds from stock option exercises.
The majority of cash used in financing activities in both periods was attributable to dividend payments on our Series A Preferred Stock, which totaled $6.8 million in each of the three-month periods ended March 31, 2025 and 2024.
Off Balance Sheet Arrangements
As of March 31, 2025 and December 31, 2024, we had no off balance sheet arrangements.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America, which requires us to make estimates and assumptions that affect the reported amounts in our condensed consolidated financial statements. Critical accounting estimates are those that management believes are the most important to the portrayal of our financial condition and results and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and that have had, or are reasonably likely to have, a material impact on our financial condition or results of operations. Judgments and uncertainties may result in materially different amounts being reported under different conditions or using different assumptions. There have been no material changes to our critical accounting policies or estimates from those described in Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations included in our 2024 Annual Report.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
In the normal course of business, our financial position is routinely subject to a variety of risks. The principal market risks (i.e., the risk of loss arising from adverse changes in market rates and prices) to which we are exposed are fluctuations in commodity and other input prices affecting the costs of our raw materials (including, but not limited to, increases in the costs of the price of aluminum cans, sucralose and other sweeteners, as well as other raw materials contained within our products). We do not currently use hedging agreements or other financial instruments to manage the risks associated with securing sufficient ingredients or raw materials, although we may consider doing so in the future as part of our risk management strategy. We are also subject to market risks with respect to the cost of commodities and other inputs because our ability to recover increased costs through higher pricing is limited by the competitive environment in which we operate.
We do not use derivative financial instruments to protect ourselves from fluctuations in interest rates and do not hedge against fluctuations in commodity prices.
There have been no material changes to the information regarding market risk provided in Item 7A. Quantitative and Qualitative Disclosures about Market Risk contained in our 2024 Annual Report.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms adopted by the SEC. These controls also ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act are accumulated and communicated to the Company’s management, including our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial and accounting officer), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.
Our Chief Executive Officer, as well as our Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2025. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) during the quarter ended March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Part II - Other Information
Item 1. Legal Proceedings.
The information required by this Item is included in Note 14. Commitments and Contingencies in the condensed consolidated financial statements in Part I, Item 1 of this Report.
Item 1A. Risk Factors.
We face a variety of risks that are inherent in our business and our industry, including operational, legal, regulatory and product risks. Such risks could cause our actual results to differ materially from our forward-looking statements, expectations and historical trends. During the reporting period covered by this Report, there have been no material changes to our risk factors as set forth in Part I, Item 1A Risk Factors in our 2024 Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
During the three months ended March 31, 2025, we purchased the following shares of our common stock to satisfy the employee tax withholding obligations upon the vesting of equity awards:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Period | | Total Number of Shares Purchased | | Average Price Paid per Share | | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | | Maximum Dollar Value that May Yet Be Purchased Under the Plans or Programs |
January 1, 2025 to January 31, 2025 | | 47,602 | | | $ | 25.86 | | | — | | | $ | — | |
February 1, 2025 to February 28, 2025 | | 2,640 | | | 32.62 | | | — | | | — | |
March 1, 2025 to March 31, 2025 | | 23,071 | | | $ | 25.69 | | | — | | | — | |
Total | | 73,313 | | | | | — | | | $ | — | |
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
Rule 10b5-1 Trading Arrangements
From time to time, certain of our executive officers and directors have, and we expect they will in the future, enter into, amend and terminate written trading arrangements pursuant to Rule 10b5-1 of the Exchange Act or otherwise. During the quarter ended March 31, 2025, except as set forth below, none of our officers or directors adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).
| | | | | | | | | | | | | | | | | |
Name and Title | Type of Plan | Participant's Adoption Date | Termination Date or Date Terminated by Participant | Aggregate Number of Securities | Description of Trading Arrangement |
John Fieldly, Chief Executive Officer | 10b5-1(c)(1) Trading Plan | September 13, 2024 | Terminated by Mr. Fieldly on March 6, 2025 | 311,605 | Sale of shares of common stock (vested stock options or other awards) |
John Fieldly, Chief Executive Officer | 10b5-1(c)(1) Trading Plan | March 7, 2025 | June 10, 2026 | 632,044 | Sale of shares of common stock (vested stock options or other awards) |
Item 6. Exhibits.
Index to Exhibits
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Exhibit | | | | Incorporated by Reference |
Number | | Exhibit Description | | Form | | Exhibit | | Filing Date |
| | | | 8-K | | 2.1 | | 2/20/2025 |
| | | | | | | | |
| | | | 10-K | | 3.1 | | 2/29/2024 |
| | | | | | | | |
| | | | 10-Q | | 3.2 | | 8/6/2024 |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
101.SCH* | | Inline XBRL Taxonomy Extension Schema Document | | | | | | |
| | | | | | | | |
101.CAL* | | Inline XBRL Taxonomy Extension Calculation Linkbase Document | | | | | | |
| | | | | | | | |
101.DEF* | | Inline XBRL Taxonomy Extension Definition Linkbase Document | | | | | | |
| | | | | | | | |
101.LAB* | | Inline XBRL Taxonomy Extension Label Linkbase Document | | | | | | |
| | | | | | | | |
101.PRE* | | Inline XBRL Taxonomy Extension Presentation Linkbase Document | | | | | | |
| | | | | | | | |
104* | | The cover page of this Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL (included within the Exhibit 101 attachment) | | | | | | |
__________________________________________________
*Filed herewith.
** Furnished herewith.
+ Certain provisions and terms of this Exhibit have been redacted in accordance with Item 601(b)(2)(ii) of Regulation S-K, because Celsius customarily and actually treats that information as private or confidential and the omitted information is not material. Celsius will supplementally provide a copy of an unredacted copy of this exhibit to the Securities and Exchange Commission or its staff upon request.
++ Management contract or compensatory plan agreement.
† Certain exhibits and schedules to this Exhibit have been omitted in accordance with Item 601 (a)(5) of Regulation S-K. Celsius agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission or its staff upon request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | |
| CELSIUS HOLDINGS, INC. |
| | |
Date: May 5, 2025 | By: | /s/ John Fieldly |
| | John Fieldly, Chief Executive Officer (Principal Executive Officer) |
| | |
Date: May 5, 2025 | By: | /s/ Jarrod Langhans |
| | Jarrod Langhans, Chief Financial Officer (Principal Financial and Accounting Officer) |